United Kingdom · Seed startup

Who invested in Concinnity Genetics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$3.8Mraised across 1 round since 2024, from 1 source

Latest round
Seed, $3.8MDec 2024
Investors
3
See who backed them

The rounds

  1. Dec 2024

Founders and team

From Concinnity Genetics's own website: 2 founders.

Jessica BirtCEO and Co-founder
Dr Matthew DaleCSO and Co-founder

Everyone who backed them

Scottish EnterpriseGovernment1round
Maven Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Concinnity Genetics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

EosAngel networkPer its own site

Quick answers about Concinnity Genetics

Who invested in Concinnity Genetics?

Concinnity Genetics's investors include Scottish Enterprise, Maven Capital Partners and Old College Capital Lp.

How much has Concinnity Genetics raised?

Concinnity Genetics has raised $3.8M across 1 round since 2024.

When did Concinnity Genetics last raise?

Concinnity Genetics's most recent round was a Seed of $3.8M in Dec 2024.

What was Concinnity Genetics's biggest round?

Its most recent round, $3.8M in Dec 2024, is also its largest on record.

Who backed Concinnity Genetics first?

Concinnity Genetics's first round on record, in Dec 2024, was backed by Scottish Enterprise, Maven Capital Partners and Old College Capital Lp.

What stage is Concinnity Genetics at?

Concinnity Genetics's latest named round is a Seed, in Dec 2024.

Where is Concinnity Genetics based?

Concinnity Genetics is based in the United Kingdom.

Companies like Concinnity Genetics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.